Sigmatic Sciences has integrated NVIDIA's latest BioNeMo Agent Toolkit into its SigmaticOS platform, creating an advanced AI Scientist capable of orchestrating data, models, software, and lab experiments in a unified, traceable workflow. This integration enhances the ability to connect AI agents with scientific tools and laboratory systems, enabling scalable and reproducible scientific discovery with human oversight. The platform supports over 300 specialized scientific agents and connects to various data sources and lab infrastructures, accelerating drug discovery by closing the loop between computational models and physical experiments. Sigmatic Sciences will demonstrate these capabilities at the BIO International Convention in June 2026.
Nvidia introduced Cosmos 3 Edge, a new AI model designed for robots and vision AI agents to navigate physical environments in real time. The company is expanding its AI ecosystem in Japan by partnering with major local firms like Fujitsu, Hitachi, an...
Netlist has prompted the US International Trade Commission (ITC) to investigate Samsung and its customers Google, Supermicro, Nvidia, and Broadcom for allegedly infringing two Netlist patents related to Samsung's high-bandwidth memory and DDR5 memory...
NVIDIA and Noetra Corp. are partnering to build Japan's first national AI infrastructure, the NVIDIA Vera Rubin AI factory, featuring 13,750 Vera CPUs and 27,500 Rubin GPUs. Supported by Japan's Ministry of Economy, Trade and Industry, this 140-megaw...
NVIDIA announced that leading Japanese companies in robotics and manufacturing are adopting its Cosmos, Isaac, Metropolis, and Jetson platforms to accelerate AI-powered intelligent machines across industries. The new Cosmos 3 Edge model enables real-...
The SPDR NYSE Technology ETF (XNTK) has significantly outperformed the Invesco QQQ Trust (QQQ) over the past year, returning 51.65% compared to QQQ's 28.43%. XNTK uses an equal-weight approach focusing solely on about 35 tech leaders, capturing broad...
